Abstract
This paper examines the application of Results Based Management (RBM) in a health program aimed at combating noncommunicable diseases (NCDs) in rural Egypt. The study focuses on a three-year initiative implemented from 2019 to 2022 across five governorates, targeting diabetes, hypertension, and cardiovascular diseases. Using a mixed-methods approach, we analyze the program’s design, implementation, and outcomes through the lens of RBM principles.
Our findings indicate that the adoption of RBM led to improved goal clarity, enhanced monitoring and evaluation processes, and increased accountability among stakeholders. The program achieved a 15% reduction in NCD-related mortality and a 22% increase in early detection rates. However, challenges were encountered in data collection and local capacity building.
This case study contributes to the growing body of literature on RBM in public health contexts, particularly in resource-limited settings. We conclude by offering recommendations for policymakers and program managers on effectively integrating RBM into health initiatives targeting NCDs in similar environments.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the HealthForAll Fund, grant number HF-BD-2734.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocol received approval from the ResearchOcrats Health Ethics Committee (Approval No. ERM-3480-9891). Informed consent was obtained from all participants, and data anonymization measures were implemented to ensure participant privacy.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
